Whole genome sequencing (WGS) analysis provides a complete, base-level readout of an organism's DNA, enabling high-resolution detection of single nucleotide variants, insertions and deletions, copy number changes, and large structural rearrangements. This technical guide explains the sequencing workflow, sample requirements, core testing items, bioinformatics methods, and practical applications across clinical, agricultural, and microbiological fields. All procedures described below can be performed by accredited third-party laboratories operating under ISO/IEC 17025 quality management frameworks.
Technical Overview
Whole genome sequencing analysis is the process of determining the complete DNA sequence of an organism's genome—including chromosomes, and in many cases the mitochondrial or plastid genome—followed by computational interpretation of the resulting data. Unlike targeted panels or exome sequencing, WGS captures coding regions, introns, promoters, enhancers, repetitive elements, and intergenic regions, delivering an unbiased and comprehensive view of genomic variation. This completeness makes WGS the reference standard for variant discovery, genome assembly, and molecular characterization.
Modern WGS relies on two complementary technology classes. Short-read platforms based on sequencing-by-synthesis typically generate paired-end reads of 100–300 base pairs with very high per-base accuracy (commonly reported as a high percentage of bases above Q30) and high throughput, making them well suited for reference-guided variant calling in large genomes. Long-read platforms, including single-molecule real-time sequencing and nanopore sequencing, produce reads ranging from several kilobases to megabases, which dramatically improve the resolution of structural variants, repetitive regions, phasing, and de novo assembly. Hybrid strategies that combine both read types are increasingly used for high-contiguity reference-grade assemblies.
A typical human germline WGS study targets a mean depth of 30× coverage, meaning each genomic position is sequenced approximately thirty times on average. Tumor-normal paired studies often require 60×–100× depth for the tumor genome to maintain sensitivity in low-purity or heterogeneous specimens. Microbial WGS is frequently performed at 100× depth or higher to support closed or near-closed draft assemblies. Key quality metrics monitored throughout the workflow include raw read quality, base quality distribution, duplication rate, mapping rate, insert-size distribution, coverage uniformity, genome coverage breadth, and transition-to-transversion ratio.
Laboratories offering WGS services typically operate under recognized quality frameworks. ISO/IEC 17025 governs the general competence of testing laboratories, ISO 15189 applies to medical laboratories performing clinical genomic testing, and ISO 20387 addresses biobanking requirements for sample collection, transport, and storage. Clinical variant interpretation is generally performed according to professional society guidelines issued by standards organizations such as the American College of Medical Genetics and Genomics together with the Association for Molecular Pathology, while clinical laboratory practice documents from the Clinical and Laboratory Standards Institute provide methodological guidance for next-generation sequencing workflows.
Testing Samples
Human Biological Samples
Accepted human specimen types include peripheral blood collected in EDTA anticoagulant tubes, saliva or buccal swabs collected in stabilizing buffer, and fresh-frozen tissue. Blood is generally preferred for germline testing because it provides high-molecular-weight genomic DNA from leukocytes with minimal degradation. Formalin-fixed paraffin-embedded (FFPE) tissue can also be processed for tumor-normal comparative analysis; however, fixation-induced cross-linking and fragmentation reduce yield and increase the risk of artifacts, so dedicated low-input or degradation-tolerant library protocols are applied.
- Blood: typically 1–2 mL, with genomic DNA extracted and quantified by fluorometric assay.
- Saliva or buccal swab: collected per the sampling kit protocol to minimize bacterial DNA content.
- Fresh-frozen tissue: recommended minimum 20–30 mg with confirmation of tumor cellularity for oncology studies.
- FFPE tissue: 5–10 sections at 5–10 micrometer thickness, with a pathology-verified tumor content typically above 20–30 percent.
Animal and Livestock Samples
Animal genome projects accept blood, ear notch tissue, hair follicles with roots, tail tips, and semen samples. For livestock breeding programs, ear notches and hair follicles are popular because collection is minimally invasive and DNA remains stable during dry transport. Samples are shipped chilled or at ambient temperature in stabilizing media, and DNA integrity is verified by electrophoretic assessment before library construction.
Plant Samples
Plant WGS commonly uses young leaves, seedlings, or callus tissue harvested at growth stages with low polysaccharide and polyphenol content. Because plant matrices contain secondary metabolites that inhibit enzymatic reactions, specialized extraction chemistry incorporating CTAB-based or commercial plant DNA isolation methods is employed. Purity is assessed by spectrophotometric ratios (A260/A280 near 1.8 and A260/A230 above 2.0), and integrity is confirmed by gel or capillary electrophoresis. For large or polyploid plant genomes, long-read sequencing with ultra-high-molecular-weight DNA is recommended, often combined with Hi-C scaffolding for chromosome-level assembly.
Microbial Cultures and Environmental Samples
Bacterial isolates are submitted as pure cultures on agar plates, in glycerol stocks, or as extracted DNA, with purity confirmed by morphological and biochemical characterization to rule out mixed cultures. Fungal and parasitic organisms may require different lysis strategies to break rigid cell walls. Environmental and metagenomic samples, such as soil, water, or swabs, are accepted for shotgun metagenomic sequencing when a community-level rather than isolate-level analysis is required. For all microbial submissions, accompanying metadata such as isolate source, isolation date, and suspected species improves downstream contextual analysis.
Testing Items
Whole genome sequencing analysis can be configured to deliver a broad portfolio of testing items depending on study objectives. Common deliverables include the following:
- Single nucleotide variants (SNVs): base-level substitutions assessed genome-wide, including coding, splice-region, promoter, and deep intronic variants.
- Insertions and deletions (InDels): small sequence length changes from 1 to approximately 50 base pairs.
- Copy number variants (CNVs): deletions and duplications from sub-kilobase to chromosomal scale, detected from read-depth signals.
- Structural variants (SVs): inversions, translocations, large insertions and deletions, and complex rearrangements, resolved with highest fidelity using long reads.
- Mitochondrial genome analysis: circularized assembly or depth-normalized analysis of the mitochondrial genome, including heteroplasmy estimation.
- Phasing and haplotyping: assignment of variants to parental haplotypes using long reads or linked-read methods.
- Repeat expansions: detection of pathogenic short tandem repeat expansions in selected loci where read length and chemistry permit.
- Tumor mutational burden (TMB): enumeration of somatic coding mutations per megabase in tumor-normal comparative studies.
- Microsatellite instability (MSI): genome-wide assessment of microsatellite length alterations in oncology applications.
- Germline variant classification: annotation and ACMG/AMP-conformant classification of pathogenic, likely pathogenic, uncertain-significance, benign, and likely benign findings.
- De novo assembly: contig and scaffold construction, genome size and repeat content estimation, and completeness assessment using conserved single-copy gene benchmarks.
- Genome annotation: prediction of protein-coding genes, non-coding RNAs, and functional annotation through curated databases.
- Comparative genomics and phylogenetics: variant-based clustering, pan-genome analysis, and evolutionary relationship reconstruction.
- Antimicrobial resistance and virulence profiling: identification of resistance determinants and virulence factors in microbial genomes.
Testing Methods
Sample Receipt and Quality Control
Upon arrival, every sample is accessioned into a laboratory information management system that tracks chain of custody, storage temperature, and processing timeline. DNA concentration is measured by fluorometric methods, which selectively detect double-stranded DNA and are less affected by contaminants than absorbance-based approaches. Integrity is evaluated by agarose gel electrophoresis or automated capillary electrophoresis to generate a DNA integrity number; germline short-read workflows generally require a minimal integrity threshold, whereas long-read assembly demands intact high-molecular-weight DNA above a defined size distribution. Samples failing acceptance criteria trigger communication with the submitter for re-collection before sequencing proceeds.
Library Preparation
For short-read WGS, genomic DNA is fragmented by acoustic shearing to a target insert size, followed by end repair, A-tailing, adapter ligation, and index barcoding. PCR-free library construction is preferred when input DNA is abundant, as it eliminates PCR-introduced bias and artifacts and improves coverage uniformity across GC-rich and GC-poor regions. Low-input protocols with limited-cycle PCR amplification are applied for precious or degraded specimens. For long-read WGS, high-molecular-weight DNA is carefully handled to avoid shearing, and libraries are prepared with minimal fragmentation steps using ligation-based or rapid transposase-based chemistries, optionally with adaptive sampling or size selection to optimize read length distribution.
Sequencing
Barcoded libraries are pooled and loaded onto high-capacity flow cells and sequenced to the study-design depth. Short-read runs commonly use paired-end 150-cycle chemistry, and real-time monitoring confirms cluster density, base calling quality, and the percentage of bases achieving Q30 or higher. Long-read runs are monitored for read length distribution, total yield, and per-read quality scores. Demultiplexing assigns reads to individual samples based on index sequences, and raw data are archived in standard formats before transfer to the bioinformatics pipeline.
Bioinformatics Analysis
The computational workflow follows a structured, version-controlled pipeline. Raw reads undergo quality assessment examining per-base quality, adapter contamination, and GC distribution, followed by trimming and filtering where necessary. Reads are then aligned to an appropriate reference genome using well-established short-read or long-read mappers, producing alignment files that are coordinate-sorted, duplicate-marked or duplicate-corrected, and base-quality recalibrated. Variant calling is performed with validated callers selected according to variant class: joint-calling or deep-learning-based callers for SNVs and small InDels, read-depth or assembly-based callers for CNVs, and split-read, local-assembly, or long-read-aware algorithms for structural variants. De novo assembly projects instead follow a path of error correction, assembly, polishing, scaffolding, contamination screening, and completeness evaluation. All variants are annotated with gene context, functional consequence, population frequencies, and disease or trait associations from curated public databases, after which clinically relevant findings are classified per ACMG/AMP guidelines and research findings are summarized in interpretation reports.
Validation and Reporting
Analytical validation establishes sensitivity, specificity, precision, and limit of detection for each variant class using reference materials such as genome-in-a-bottle style reference DNA and in-house confirmed specimens. Orthogonal confirmation by Sanger sequencing or an independent molecular method is commonly applied to reportable pathogenic findings or variants of special interest. Final deliverables typically include raw sequencing data files, alignment files, variant call files, genome browser-ready tracks, quality control summaries, and a comprehensive interpretive report. Human genomic data are handled under strict confidentiality controls consistent with applicable data protection regulations, with specimen and data retention periods defined in the service agreement.
Applications
Whole genome sequencing analysis supports a remarkably wide range of clinical, research, and industrial use cases:
- Rare disease diagnostics: identification of pathogenic variants in patients with unresolved genetic conditions, including non-coding variants missed by exome sequencing, often ending a lengthy diagnostic odyssey.
- Precision oncology: comprehensive tumor-normaline comparative profiling to identify actionable somatic mutations, CNVs, structural variants, MSI status, TMB, and mutational signatures informing therapy selection.
- Pharmacogenomics: genome-wide determination of variants affecting drug metabolism and response to guide individualized dosing.
- Reproductive genetics: expanded carrier screening, preconception risk assessment, and prenatal diagnostic evaluation of chromosomal and monogenic conditions.
- Agrigenomics and crop improvement: whole-genome variant discovery in breeding populations, genome-wide association studies, genomic selection, and construction of chromosome-scale reference genomes for major and orphan crops.
- Livestock and companion animal breeding: detection of markers for production traits, disease susceptibility, and breed diversity, together with parentage verification.
- Public health microbiology: high-resolution outbreak tracing, source attribution, and surveillance of foodborne and healthcare-associated pathogens.
- Antimicrobial resistance monitoring: genome-based detection of resistance genes and mutations to support stewardship programs in human and veterinary medicine.
- Industrial biotechnology: genome characterization of production strains, strain authentication, and comparative analysis of engineered microbial cell banks.
- Conservation and evolutionary biology: population genomics of endangered species, hybridization assessment, and reconstruction of phylogeographic history.
- Forensic and identity testing: high-resolution human identification and microbial source attribution using genome-level markers.
- Environmental metagenomics: functional and taxonomic profiling of microbial communities in soil, water, and built environments.
FAQ
What is the difference between whole genome sequencing and whole exome sequencing?
Whole exome sequencing targets only the protein-coding exons, which represent roughly one to two percent of the human genome, while whole genome sequencing covers essentially all genomic sequence including introns, promoters, enhancers, and non-coding RNAs. WGS therefore detects non-coding pathogenic variants, structural rearrangements, and mitochondrial variants with far greater sensitivity, whereas exome sequencing remains a lower-cost option when the analytical focus is strictly on coding regions.
How much DNA and what sample volume are required?
Typical requirements are approximately 500 ng to 1 microgram of high-quality genomic DNA for standard PCR-free short-read libraries, and 1–3 micrograms of intact high-molecular-weight DNA for long-read assembly projects. Low-input protocols can work with as little as 10–50 ng for suitable specimen types. In practice this corresponds to 1–2 mL of whole blood, a standard saliva collection, or a small tissue fragment, and accredited third-party laboratories verify quantity and integrity before proceeding.
What sequencing depth should I choose?
A mean depth of 30× is the accepted standard for human germline WGS and reliably detects heterozygous SNVs and small InDels. Tumor-normal comparative studies generally use 60×–100× tumor depth with a 30×–50× matched normal. Microbial isolate assembly typically uses 100× or higher depth. Deeper coverage increases sensitivity for low-frequency subclonal variants and improves mosaicism detection, and study-specific recommendations are provided during project consultation.
Can FFPE samples be sequenced?
Yes. FFPE tissue can be sequenced using degradation-tolerant library protocols, and this is routine in oncology projects. Fixation artifacts such as C-to-T transitions and short fragment lengths are managed through dedicated bioinformatics filters, UMI-based error suppression, and matched normal comparison. Sample quality is graded on arrival, and suboptimal specimens may require adjusted depth or re-collection.
How long does a WGS project take?
Standard germline short-read WGS with analysis commonly completes within two to four weeks from sample receipt. Tumor-normal comparative projects and long-read assembly projects, which involve additional polishing, scaffolding, and curation, may require four to eight weeks. Complex de novo assemblies of large polyploid plant genomes can extend further depending on genome size and desired contiguity.
What deliverables will I receive?
Standard deliverables include raw sequencing data files, demultiplexed read files, alignment files, variant call files, genome assembly files where applicable, quality control metrics, bioinformatics analysis documentation, and a final interpretive report describing reportable findings and their classification according to applicable professional guidelines.
How is the privacy of human genomic data protected?
Human genomic data are de-identified at accessioning, stored on secured access-controlled infrastructure, and processed under confidentiality agreements consistent with applicable data protection frameworks. Data retention periods, deletion schedules, and any controlled-access data sharing are specified in the service contract before sequencing begins.
Which quality standards apply to WGS services?
Accredited third-party laboratories typically operate under ISO/IEC 17025 general requirements for testing laboratory competence, while clinical genomic laboratories align with ISO 15188 medical laboratory requirements—more precisely ISO 15189—and biobanking procedures follow ISO 20387. Methodological guidance for next-generation sequencing is further informed by clinical laboratory standards organizations such as the Clinical and Laboratory Standards Institute, and clinical variant interpretation follows consensus guidelines issued by professional societies including the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.